Home Cart Sign in  
Chemical Structure| 749234-11-5 Chemical Structure| 749234-11-5

Structure of DMAT
CAS No.: 749234-11-5

Chemical Structure| 749234-11-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

DMAT is a potent and specific CK2 inhibitor with an IC50 value of 130 nM.

Synonyms: Casein kinase II Inhibitor; CK2 Inhibitor; 2-Dimethylamino-4,5,6,7-tetrabromobenzimidazole

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of DMAT

CAS No. :749234-11-5
Formula : C9H7Br4N3
M.W : 476.79
SMILES Code : CN(C)C1=NC2=C(Br)C(Br)=C(Br)C(Br)=C2N1
Synonyms :
Casein kinase II Inhibitor; CK2 Inhibitor; 2-Dimethylamino-4,5,6,7-tetrabromobenzimidazole
MDL No. :MFCD08705322

Safety of DMAT

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Related Pathways of DMAT

DNA
Hedgehog

Isoform Comparison

Biological Activity

Target
  • CK2

    CK2, Ki:~40 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
SkChA-1 10 µM 72 hours DMAT significantly reduces cell viability and induces apoptosis PMC3226029
HMDM cells 1μM 15h DMAT significantly stimulated HMDM cells to kill VRE bacteria PMC11091880
RAW264.7 cells 1μM 15h CU-CPT22 significantly inhibited Pam3CSK4-induced TRL2/1 signaling PMC11091880
3T3-L1 cells 30 µM Inhibited adipogenesis in 3T3-L1 cells PMC8401933
GBC 10 µM 72 hours DMAT significantly reduces cell viability and induces apoptosis PMC3226029
MzChA-2 10 µM 72 hours DMAT significantly reduces cell viability and induces apoptosis PMC3226029
MzChA-1 10 µM 72 hours DMAT significantly reduces cell viability and induces apoptosis PMC3226029
TFK 10 µM 72 hours DMAT significantly reduces cell viability and induces apoptosis PMC3226029
EGI-1 10 µM 72 hours DMAT significantly reduces cell viability and induces apoptosis PMC3226029
CCLP-1 10 µM 72 hours DMAT significantly reduces cell viability, induces apoptosis, and inhibits Wnt signaling pathway PMC3226029
Non-cancerous cells (Vero) 1.575–100 μM 48 hours To evaluate the cytotoxicity of DMAT derivatives on Vero cells, results showed all tested compounds significantly reduced cell viability with IC50 values ranging from 9.66 μM to 41.53 μM. PMC10385865
Breast cancer (MCF-7) 1.575–100 μM 48 hours To evaluate the cytotoxicity of DMAT derivatives on MCF-7 cells, results showed all tested compounds significantly reduced cell viability with IC50 values ranging from 9.66 μM to 41.53 μM. PMC10385865
Human chronic myelogenous leukemia (K-562) 1.575–100 μM 48 hours To evaluate the cytotoxicity of DMAT derivatives on K-562 cells, results showed all tested compounds significantly reduced cell viability with IC50 values ranging from 9.66 μM to 41.53 μM. PMC10385865
Acute lymphoblastic leukemia (CCRF-CEM) 1.575–100 μM 48 hours To evaluate the cytotoxicity of DMAT derivatives on CCRF-CEM cells, results showed all tested compounds significantly reduced cell viability with IC50 values ranging from 9.66 μM to 41.53 μM. PMC10385865
A549 cells 2.5 or 12.5 µM 20 hours Inhibited RSK4 activation, resulting in decreased cellular cIAP1 and cIAP2 expression PMC3302271
Human brain microvascular endothelial cells (HBMVEC) 50-100 μM 8 hours DMAT induced dramatic changes in cell shape, including cell retraction and rounding, which were reversible within 8 hours. PMC3426611
Human astrocytes (HAST-40) 50-100 μM 6 hours DMAT induced dramatic changes in cell shape, including cell retraction and rounding, which were reversible within 6 hours. PMC3426611
CCSW-1 10 µM 72 hours DMAT significantly reduces cell viability and induces apoptosis PMC3226029
UM-SCC-46 10, 20 μM 48 hours Inhibited mRNA expression of CSC marker genes Nanog, Oct4, and Sox2 PMC4212254
UM-SCC-22A 10, 20 μM 48 hours Inhibited mRNA expression of CSC marker genes Nanog, Oct4, and Sox2 PMC4212254
H1299 cells 2.5 or 12.5 µM 20 hours Inhibits HSP accumulation, thereby suppressing thermotolerance PMC3302271
BDC 10 µM 72 hours DMAT significantly reduces cell viability and induces apoptosis PMC3226029

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Wound infection model IP injection 5mg/kg Single dose DMAT significantly reduced VRE bacterial load in wounds PMC11091880

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.10mL

0.42mL

0.21mL

10.49mL

2.10mL

1.05mL

20.97mL

4.19mL

2.10mL

References

 

Historical Records

Categories